The Role of Innovative Medications in the Expanding ALS Treatment Industry
The global Amyotrophic Lateral Sclerosis (ALS) treatment market is witnessing steady growth as healthcare providers, researchers, and pharmaceutical companies intensify efforts to address one of the most challenging neurodegenerative diseases. Valued at US$ 594.1 million in 2022, the market is projected to expand at a CAGR of 5.5% from 2023 to 2031 and surpass US$ 958.2 million by the end of...
0 Yorumlar 0 hisse senetleri 47 Views 0 önizleme